Mechanisms of the inhibitory effects of amyloid β-protein on synaptic plasticity

Experimental Gerontology

Volumn 39, Issue 11-12 SPEC. ISS., 2004, Pages 1661-1667

  Rowan, Michael J ^a   Klyubin, Igor ^a   Wang, Qinwen ^a   Anwyl, Roger ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Amyloid protein oligomers; CA1 area; Early Alzheimer's disease; Glutamatergic transmission; Hippocampus; Long term potentiation; Medial perforant path; Mild Cognitive Impairment; Oxidative stress; Rodent model

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE;

ALZHEIMER DISEASE; CONFERENCE PAPER; CYTOPATHOLOGY; ENZYME ACTIVATION; EXPERIMENTAL ANIMAL; HIPPOCAMPUS; LONG TERM POTENTIATION; MENTAL STRESS; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; RODENT; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; DISEASE PROGRESSION; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MODELS, ANIMAL; MUTATION; NEURONAL PLASTICITY; OXIDATIVE STRESS; RATS;

ANIMALIA; RODENTIA;

EID: 9644284689     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2004.06.020     Document Type: Conference Paper

References (57)

1. K.T. Akama, and L.J.V. Van Eldik β-amyloid stimulation of inducible nitric oxide synthase in astrocytes is IL-1β and TNF-α dependent J. Biol. Chem. 275 2000 7918 7924
2. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and T. Wyss-Coray Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421
3. K.H. Ashe Learning and memory in transgenic mice modeling Alzheimer's disease Learn. Mem. 8 2001 301 308
4. K.J. Barnham, C.L. Masters, and A.I. Bush Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discov. 3 2004 205 214
5. L. Canevari, A.Y. Abramov, and M.R. Duchen Toxicity of amyloid β peptide: tales of calcium, mitochondria, and oxidative stress Neurochem. Res. 29 2004 637 650
6. B. Caughey, and P.T. Lansbury Jr Protofibrils, pores, fibrils, and neurodegeneration:separating the responsible protein aggregates from the innocentbystanders Annu. Rev. Neurosci. 26 2003 267 298
7. W.K. Cullen, Y.-H. Suh, R. Anwyl, and M.J. Rowan Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments NeuroReport 8 1997 3213 3217
8. K.N. Dahlgren, A.M. Manelli, W.B. Stine Jr., L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053
9. N. Demeester, C. Mertens, H. Caster, M. Goethals, J. Vandekerckhove, M. Rosseneu, and C. Labeur Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid β peptides Eur. J. Neurosci. 13 2001 2015 2024
10. C.M. Dobson Getting out of shape Nature 418 2002 729 730
11. I. Ferrer, M. Boada Rovira, M.L. Sanchez Guerra, M.J. Rey, and F. Costa-Jussa Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer's disease Brain Pathol. 14 2004 11 20
12. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297 2002 353 356
13. K. Hensley, R.A. Floyd, N.Y. Zheng, R. Nael, K.A. Robinson, X. Nguyen, Q.N. Pye, C.A. Stewart, J. Geddes, W.R. Markesbery, E. Patel, G.V. Johnson, and G. Bing p38 kinase is activated in the Alzheimer's disease brain J. Neurochem. 72 1999 2053 2058
14. H. Hering, and M. Sheng Dendritic spines: structure, dynamics and regulation Nat. Rev. Neurosci. 2 2001 880 888
15. C. Hock, U. Konietzko, J.R. Streffer, J. Tracy, A. Signorell, B. Muller-Tillmanns, U. Lemke, K. Henke, E. Moritz, E. Garcia, M.A. Wollmer, D. Umbricht, D.J. de Quervain, M. Hofmann, A. Maddalena, A. Papassotiropoulos, and R.M. Nitsch Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease Neuron 38 2003 547 554
16. L.A. Holcomb, M.N. Gordon, P. Jantzen, K. Hsiao, K. Duff, and D. Morgan Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits Behav. Genet. 29 1999 177 185
17. C. Janus, M. Chishti, and D. Westaway Transgenic mouse models of Alzheimer's disease Biochim. Biophys. Acta 1502 2000 63 75
18. K. Kamino, H.T. Orr, H. Payami, E.M. Wijsman, M.E. Alonso, S.M. Pulst, L. Anderson, S. O'dahl, E. Nemens, J.A. White, A.D. Sadovnick, M.J. Ball, J. Kaye, A. Warren, M. Mcinnis, S.E. Antonarakis, J.R. Korenberg, V. Sharma, W. Kukull, E. Larson, L.L. Heston, G.M. Martin, T.D. Bird, and G.D. Schellenberg Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region Am. J. Hum. Genet. 51 1992 998 1014
19. A. Kamsler, and M. Segal Paradoxical actions of hydrogen peroxide on long-term potentiation in transgenic superoxide dismutase-1 mice J. Neurosci. 23 2003 10359 10367
20. S.H. Kim, C.J. Smith, and L.J. Van Eldik Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production Neurobiol. Aging 25 2004 431 439
21. W.L. Klein, G.A. Krafft, and C.E. Finch Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24 2001 219 224
22. I. Klyubin, D.M. Walsh, W.K. Cullen, J.V. Fadeeva, R. Anwyl, D.J. Selkoe, and M.J. Rowan Soluble Arctic amyloid β protein inhibits hippocampal long-term potentiation in vivo Eur. J. Neurosci. 19 2004 2839 2846
23. M.P. Laakso Structural imaging in cognitive impairment and the dementias: an update Curr. Opin. Neurol. 15 2002 415 421
24. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel, and J. Rogers Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862
25. M.A. Lynch Long-term potentiation and memory Physiol. Rev. 84 2004 87 136
26. P.L. McGeer, and E.G. McGeer The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases Brain Res. Rev. 21 1995 195 218
27. E.G. McGeer, and P.L. McGeer Inflammatory processes in Alzheimer's disease Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2004 741 749
28. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush, and C.L. Masters Soluble pool of Ab amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
29. D. Morgan Learning and memory deficits in APP transgenic mouse models of amyloid deposition Neurochem. Res. 28 2003 1029 1034
30. D. Morgan, D.M. Diamond, P.E. Gottschall, K.E. Ugen, C. Dickey, J. Hardy, K. Duff, P. Jantzen, G. DiCarlo, D. Wilcock, K. Connor, J. Hatcher, C. Hope, M. Gordon, and G.W. Arendash Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 2000 982 985
31. R.G.M. Morris, E.I. Moser, G. Riedel, S.J. Martin, J. Sandin, M. Day, and C. O'Carroll Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory Phil. Trans. R. Soc. Lond. B Biol. Sci. 358 2003 773 786
32. K. Murakami, K. Irie, A. Morimoto, H. Ohigashi, M. Shindo, M. Nagao, T. Shimizu, and T. Shirasawa Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ 1-42 mutants of familial Alzheimer's disease at positions 21-23 Biochem. Biophys. Res. Commun. 294 2002 5 10
33. K. Murakami, K. Irie, A. Morimoto, H. Ohigashi, M. Shindo, M. Nagao, T. Shimizu, and T. Shirasawa Neurotoxicity and physicochemical properties of Aβ mutant peptides from cerebral amyloid angiopathy: Implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's Disease J. Biol. Chem. 278 2003 46179 46187
34. R. Natte, M.L. Maat-Schieman, J. Haan, M. Bornebroek, R.A. Roos, and S.G. van Duinen Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles Ann. Neurol. 50 2001 765 772
35. C. Nilsberth, A. Westlind-Danielsson, C.B. Eckman, M.M. Condron, K. Axelman, C. Forsell, C. Stenh, J. Luthman, D.B. Teplow, S.G. Younkin, J. Naslund, and L. Lannfelt The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation Nat. Neurosci. 4 2001 887 893
36. J.M. Orgogozo, S. Gilman, J.F. Dartigues, B. Laurent, M. Puel, L.C. Kirby, P. Jouanny, B. Dubois, L. Eisner, S. Flitman, B.F. Michel, M. Boada, A. Frank, and C. Hock Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization Neurology 61 2003 46 54
37. M.J. Rowan, I. Klyubin, W.K. Cullen, and R. Anwyl Synaptic plasticity in animal models of early Alzheimer's disease Phil. Trans. R. Soc. Lond. B Biol. Sci. 358 2003 821 828
38. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, Z. Liao, I. Lieberburg, R. Motter, L. Mutter, F. Soriano, G. Shopp, N. Vasquez, C. Vandevert, S. Walker, M. Wogulis, T. Yednock, D. Games, and P. Seubert Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
39. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
40. D.J. Selkoe, and D. Schenk Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics Annu. Rev. Pharmacol. Toxicol. 43 2003 545 584
41. K. Sennvik, C. Nilsberth, C. Stenh, L. Lannfelt, and E. Benedikz The Arctic Alzheimer mutation enhances sensitivity to toxic stress in human neuroblastoma cells Neurosci. Lett. 326 2002 51 55
42. A.K. Sian, E.R. Frears, O.M. El-Agnaf, B.P. Patel, M.F. Manca, G. Siligardi, R. Hussain, and B.M. Austen Oligomerization of β-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types Biochem. J. 349 2000 299 308
43. Z. Suo, M. Wu, B.A. Citron, G.T. Wong, and B.W. Festoff Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer's disease: an association with early β-amyloid accumulation J. Neurosci. 224 2004 3444 3452
44. B.J. Tabner, S. Turnbull, O.M. El-Agnaf, and D. Allsop Formation of hydrogen peroxide and hydroxyl radicals from Aβ and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease Free Radic. Biol. Med. 32 2002 1076 1083
45. J. Tan, T. Town, D. Paris, T. Mori, Z. Suo, F. Crawford, M.P. Mattson, R.A. Flavell, and M. Mullan Microglial activation resulting from CD40-CD40L interaction after β-amyloid stimulation Science 286 1999 2352 2355
46. R.D. Terry Cell death or synaptic loss in Alzheimer disease J. Neuropathol. Exp. Neurol. 59 2000 1118 1119
47. T. Tikka, B. Fiebich, G. Goldsteins, R. Keinanen, and J. Koistinaho Minocycline, a tetracycline derivative, is neuroprotective against excitiotoxicity by inhibiting activating and proliferation of microglia J. Neurosci. 21 2001 2580 2588
48. N. Toni, P.A. Buchs, I. Nikonenko, C.R. Bron, and D. Muller LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite Nature 402 1999 421 425
49. S.G. van Duinen, E.M. Castano, F. Prelli, G.T. Bots, W. Luyendijk, and B. Frangione Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease Proc. Natl Acad. Sci. USA 84 1987 5991 5994
50. M.M. Verbeek, P. Eikelenboom, and R.M. de Waal Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease J. Neuropathol. Exp. Neurol. 56 1997 751 761
51. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
52. Q. Wang, M.J. Rowan, and R. Anwyl β-Amyloid-mediated inhibition of LTP induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide J. Neurosci. 24 2004 6049 6056
53. Q. Wang, D.M. Walsh, M.J. Rowan, D.J. Selkoe, and R. Anwyl Block of long-term potentiation by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5 J. Neurosci. 24 2004 3370 3378
54. A.R. Wattendorf, G.T. Bots, L.N. Went, and L.J. Endtz Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage J. Neurol. Sci. 55 1982 121 135
55. J. Yrjanheikk, R. Keinnanen, M. Pellikka, T. Hokfelt, and J. Koistinaho Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischaemia Proc. Natl Acad. Sci. USA 95 1998 15769 15774
56. S. Zhu, I.G. Stavrovskaya, M. Drozda, B.Y. Kim, V. Ona, M. Li, S. Sarang, A.S. Liu, D.M. Hartley, C. Wu du, S. Gullans, R.J. Ferrante, S. Przedborski, B.S. Kristal, and R.M. Friedlander Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature 417 2002 74 78
57. X. Zhu, A.K. Raina, H.G. Lee, G. Casadesus, M.A. Smith, and G. Perry Oxidative stress signalling in Alzheimer's disease Brain Res. 1000 2004 32 39